Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study

Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. Methods: We conducted a before-and-after comparat...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Therapeutic advances in chronic disease Ročník 12; s. 20406223211005275
Hlavní autoři: Chambord, Jeremy, Couzi, Lionel, Merville, Pierre, Moreau, Karine, Xuereb, Fabien, Djabarouti, Sarah
Médium: Journal Article
Jazyk:angličtina
Vydáno: London, England SAGE Publications 2021
SAGE PUBLICATIONS, INC
Sage
SAGE Publishing
Témata:
ISSN:2040-6223, 2040-6231
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. Methods: We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. Results: At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Conclusions: Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
AbstractList Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. Methods: We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. Results: At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Conclusions: Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG),  = 44] those who did not [control group (CG),  = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% 72.2%,  = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG),  = 44] those who did not [control group (CG),  = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% 72.2%,  = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort.AIMSTo assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort.We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure.METHODSWe conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure.At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2.RESULTSAt visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2.Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.CONCLUSIONSOur intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge about their treatment, medication adherence and exposure to treatment in a French cohort. Methods: We conducted a before-and-after comparative study between two groups of patients: those who benefited from a complementary pharmacist-led intervention [intervention group (IG), n = 44] versus those who did not [control group (CG), n = 48]. The pharmacist-led intervention consisted of a behavioral and educational interview at the first visit (visit 1). The intervention was assessed 4 months later at the second visit (visit 2), using the following endpoints: treatment knowledge, medication adherence [proportion of days covered (PDC) by immunosuppressive therapy] and tacrolimus exposure. Results: At visit 2, IG patients achieved a significantly higher knowledge score than CG patients (83.3% versus 72.2%, p = 0.001). We did not find any differences in treatment exposure or medication adherence; however, the intervention tended to reduce the proportion of non-adherent patients with low knowledge scores. Using the PDC by immunosuppressive therapy, we identified 10 non-adherent patients (10.9%) at visit 1 and six at visit 2. Conclusions: Our intervention showed a positive effect on patient knowledge about their treatment. However, our results did not show any improvement in overall medication adherence, which was likely to be because of the initially high level of adherence in our study population. Nevertheless, the intervention appears to have improved adherence in non-adherent patients with low knowledge scores.
Author Couzi, Lionel
Djabarouti, Sarah
Moreau, Karine
Chambord, Jeremy
Xuereb, Fabien
Merville, Pierre
Author_xml – sequence: 1
  givenname: Jeremy
  orcidid: 0000-0001-8729-3907
  surname: Chambord
  fullname: Chambord, Jeremy
  email: jeremy.chambord@chu-bordeaux.fr
  organization: CHU Bordeaux, Pharmacy, Bordeaux, Pessac F-33000, France
– sequence: 2
  givenname: Lionel
  surname: Couzi
  fullname: Couzi, Lionel
  organization: Univ. Bordeaux, CNRS-UMR 5164 ImmunoConcEpT, Bordeaux, France
– sequence: 3
  givenname: Pierre
  surname: Merville
  fullname: Merville, Pierre
  organization: Univ. Bordeaux, CNRS-UMR 5164 ImmunoConcEpT, Bordeaux, France
– sequence: 4
  givenname: Karine
  surname: Moreau
  fullname: Moreau, Karine
  organization: Department of Nephrology and Renal Transplantation, CHU Bordeaux, Bordeaux, Aquitaine, France
– sequence: 5
  givenname: Fabien
  surname: Xuereb
  fullname: Xuereb, Fabien
  organization: CHU Bordeaux, Pharmacy, Bordeaux, Pessac, France Univ. Bordeaux, INSERM U1034, Bordeaux, France
– sequence: 6
  givenname: Sarah
  surname: Djabarouti
  fullname: Djabarouti, Sarah
  organization: CHU Bordeaux, Pharmacy, Bordeaux, Pessac, France Univ. Bordeaux, INSERM U1034, Bordeaux, France
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33868624$$D View this record in MEDLINE/PubMed
https://hal.science/hal-03270361$$DView record in HAL
BookMark eNp9kk1v1DAQhiNUREvpD-CCInGBQ4q_4iQcKpUKaKWVuMDZmjiTXa8Se7GdlXrnh-PsloUuglwcz7zv4_F4nmcn1lnMspeUXFJaVe8YEUQyxhmlhJSsKp9kZ3OskIzTk8M_46fZRQhrkj4hORf1s-yU81rWkomz7McHtNibmLs-h3yzAj-CNiEWA3a5sRH9Fm00zua98_mIndGw245gYYljSs5WjxaGPHqwYTNAim2SKuXC-0TVzkbvhpnYYsJgAbYroE_wPMSpu3-RPe1hCHjxsJ5n3z59_HpzWyy-fL67uV4UupQyFpR22EtALXTVlBW0Jdci3Qmw0ciw1lr0bQOMYw2ybRroa6yJJFrLVghK-Hl2t-d2DtZq480I_l45MGoXcH6pwEejB1SV4LxlrCN1KUVJaqjKqmkp1l0HXHZNYl3tWZupTW3R6bIehkfQxxlrVmrptqomTCRiArzdA1ZHttvrhZpjhLOKcEm3NGnfPBzm3fcJQ1SjCRqH1Gp0U1CspCWRjeQySV8fSddu8ul1ZpVsCGWSzdW_-rP6w_m_BiMJ6F6gvQvBY3-QUKLm-VN_zV_yVEcebeJuWlIDzPBf5-XeGdJM_S7434afD6HrOg
CitedBy_id crossref_primary_10_3389_fimmu_2025_1553786
crossref_primary_10_3389_fcvm_2025_1558082
crossref_primary_10_3390_healthcare13151918
crossref_primary_10_1016_j_transproceed_2022_01_017
crossref_primary_10_1016_j_ajt_2023_04_032
crossref_primary_10_1016_j_rcsop_2025_100587
Cites_doi 10.1681/ASN.2017020216
10.1111/jan.12883
10.1002/lt.24023
10.1097/TP.0000000000002349
10.1093/ndt/gfu204
10.1681/ASN.2017030287
10.1111/ajt.12341
10.1111/ajt.13347
10.1097/TP.0000000000001040
10.1097/TP.0b013e318271d7c1
10.1111/j.1432-2277.2009.00881.x
10.1097/01.TP.0000110408.83054.88
10.1111/hex.12101
10.1111/j.1432-2277.2005.00176.x
10.1111/j.1600-6143.2007.01966.x
10.1111/j.1600-6143.2009.02793.x
10.1186/1471-2369-12-35
10.1111/j.1365-2125.2009.03493.x
10.2165/00019053-200422180-00006
10.1007/s11096-017-0436-4
10.1111/j.1600-6143.2009.02798.x
10.1177/152692480601600304
10.1016/S1544-3191(15)30093-5
ContentType Journal Article
Copyright The Author(s), 2021
The Author(s), 2021.
The Author(s), 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
licence_http://creativecommons.org/publicdomain/zero
The Author(s), 2021 2021 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
Copyright_xml – notice: The Author(s), 2021
– notice: The Author(s), 2021.
– notice: The Author(s), 2021. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: licence_http://creativecommons.org/publicdomain/zero
– notice: The Author(s), 2021 2021 SAGE Publications Ltd unless otherwise noted. Manuscript content on this site is licensed under Creative Commons Licenses
DBID AFRWT
AAYXX
CITATION
NPM
3V.
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
KB0
M0S
NAPCQ
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
1XC
5PM
DOA
DOI 10.1177/20406223211005275
DatabaseName Sage Journals GOLD Open Access 2024
CrossRef
PubMed
ProQuest Central (Corporate)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Proquest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
Hyper Article en Ligne (HAL)
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Central China
ProQuest Central
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList

PubMed
MEDLINE - Academic
Publicly Available Content Database

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: 7RV
  name: Nursing & Allied Health Database
  url: https://search.proquest.com/nahs
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2040-6231
ExternalDocumentID oai_doaj_org_article_7433b22d08564508a7579b1e8dda36d9
PMC8024450
oai:HAL:hal-03270361v1
33868624
10_1177_20406223211005275
10.1177_20406223211005275
Genre Journal Article
GeographicLocations France
GeographicLocations_xml – name: France
GroupedDBID ---
01A
0R~
4.4
53G
54M
5VS
7RV
7X7
8FI
8FJ
AAKDD
AARIX
AASGM
ABAFQ
ABAWP
ABJIS
ABQXT
ABRHV
ABUWG
ABVFX
ABXGC
ACARO
ACDXX
ACGFS
ACROE
ADBBV
ADEBD
ADOGD
ADZYD
AERKM
AEUHG
AEWDL
AFCOW
AFKRA
AFKRG
AFRWT
AFUIA
AGNHF
AJUZI
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
ARTOV
AUTPY
AYAKG
BAWUL
BCNDV
BDDNI
BENPR
BKEYQ
BKSCU
BPHCQ
BSEHC
BVXVI
CAG
CCPQU
COF
DC.
DIK
EBS
EJD
EMOBN
FYUFA
GROUPED_DOAJ
GROUPED_SAGE_PREMIER_JOURNAL_COLLECTION
GX1
H13
HMCUK
HYE
HZ~
J8X
K.F
N9A
NAPCQ
O9-
OK1
P.B
PHGZM
PHGZT
PIMPY
PQQKQ
ROL
RPM
S01
SAUOL
SCDPB
SCNPE
SFC
UKHRP
ZONMY
ZPPRI
ZRKOI
ZSSAH
AAYXX
ACHEB
AFFHD
CITATION
PPXIY
31X
AADTT
AATBZ
ABHQH
ACGZU
ACSBE
ACSIQ
ACTQU
ACUIR
AEUIJ
AEWHI
B8Z
DV7
M4V
NPM
SFK
SFT
SGV
SPJ
SPP
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PJZUB
PKEHL
PQEST
PQUKI
PRINS
7X8
PUEGO
1XC
AGMQJ
5PM
ID FETCH-LOGICAL-c566t-11def6aec4c7957ab53c4463ae9ce2e8cc4fb9a23e8a6b99af8e8060cc6b44103
IEDL.DBID BENPR
ISICitedReferencesCount 7
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000637593600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2040-6223
IngestDate Tue Oct 14 18:47:24 EDT 2025
Tue Nov 04 02:00:23 EST 2025
Tue Dec 02 06:20:57 EST 2025
Fri Sep 05 13:26:23 EDT 2025
Tue Oct 07 07:04:48 EDT 2025
Wed Feb 19 02:25:45 EST 2025
Tue Nov 18 20:53:48 EST 2025
Sat Nov 29 08:09:09 EST 2025
Tue Jun 17 22:30:49 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Renal transplantation
pharmacist-led intervention
Barrows cards
adherence
knowledge improvement
Language English
License This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
The Author(s), 2021.
licence_http://creativecommons.org/publicdomain/zero/: http://creativecommons.org/publicdomain/zero
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c566t-11def6aec4c7957ab53c4463ae9ce2e8cc4fb9a23e8a6b99af8e8060cc6b44103
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMCID: PMC8024450
ORCID 0000-0001-8729-3907
0000-0002-9213-6196
OpenAccessLink https://www.proquest.com/docview/2569012629?pq-origsite=%requestingapplication%
PMID 33868624
PQID 2569012629
PQPubID 4450848
ParticipantIDs doaj_primary_oai_doaj_org_article_7433b22d08564508a7579b1e8dda36d9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8024450
hal_primary_oai_HAL_hal_03270361v1
proquest_miscellaneous_2515069636
proquest_journals_2569012629
pubmed_primary_33868624
crossref_primary_10_1177_20406223211005275
crossref_citationtrail_10_1177_20406223211005275
sage_journals_10_1177_20406223211005275
PublicationCentury 2000
PublicationDate 2021-00-00
PublicationDateYYYYMMDD 2021-01-01
PublicationDate_xml – year: 2021
  text: 2021-00-00
PublicationDecade 2020
PublicationPlace London, England
PublicationPlace_xml – name: London, England
– name: United States
– name: Thousand Oaks
– name: Sage UK: London, England
PublicationTitle Therapeutic advances in chronic disease
PublicationTitleAlternate Ther Adv Chronic Dis
PublicationYear 2021
Publisher SAGE Publications
SAGE PUBLICATIONS, INC
Sage
SAGE Publishing
Publisher_xml – name: SAGE Publications
– name: SAGE PUBLICATIONS, INC
– name: Sage
– name: SAGE Publishing
References Denhaerynck, Dobbels, Cleemput 2005; 18
Butler, Roderick, Mullee 2004; 77
Chisholm-Burns, Spivey, Graff Zivin 2013; 13
Denhaerynck, Desmyttere, Dobbels 2006; 16
Belaiche, Décaudin, Dharancy 2017; 39
Bagnasco, Calza, Petralia 2016; 72
Takemoto, Pinsky, Schnitzler 2007; 7
Wiebe, Rush, Nevins 2017; 28
Cleemput, Kesteloot, Vanrenterghem 2004; 22
Pinsky, Takemoto, Lentine 2009; 9
Khdour, Kidney, Smyth 2009; 68
Nevins, Nickerson, Dew 2017; 28
Couzi, Moulin, Morin 2013; 95
Stemer, Lemmens-Gruber 2011; 12
Serper, Patzer, Reese 2015; 21
De Bleser, Matteson, Dobbels 2009; 22
Chisholm-Burns, Spivey, Rehfeld 2009; 9
Rodrigo, Segundo, Fernández-Fresnedo 2016; 100
Saleem, Hassali, Shafie 2015; 18
Low, Williams, Manias 2015; 30
Peipert, Hays, Kawakita 2019; 103
Wiebe, Gibson, Blydt-Hansen 2015; 15
Mathes, Großpietsch, Neugebauer 2017; 6
Salvo, Cannon-Breland 2015; 55
bibr6-20406223211005275
bibr9-20406223211005275
bibr2-20406223211005275
bibr19-20406223211005275
bibr21-20406223211005275
bibr12-20406223211005275
bibr18-20406223211005275
bibr22-20406223211005275
bibr15-20406223211005275
bibr16-20406223211005275
bibr13-20406223211005275
bibr3-20406223211005275
bibr20-20406223211005275
bibr10-20406223211005275
bibr23-20406223211005275
bibr4-20406223211005275
bibr8-20406223211005275
bibr1-20406223211005275
Mathes T (bibr11-20406223211005275) 2017; 6
bibr5-20406223211005275
bibr24-20406223211005275
bibr14-20406223211005275
bibr7-20406223211005275
bibr17-20406223211005275
References_xml – volume: 9
  start-page: 2497
  year: 2009
  end-page: 2504
  article-title: Immunosuppressant therapy adherence and graft failure among pediatric renal transplant recipients
  publication-title: Am J Transplant
– volume: 21
  start-page: 22
  year: 2015
  end-page: 28
  article-title: Medication misuse, nonadherence, and clinical outcomes among liver transplant recipients
  publication-title: Liver Transpl
– volume: 9
  start-page: 2597
  year: 2009
  end-page: 2606
  article-title: Transplant outcomes and economic costs associated with patient noncompliance to immunosuppression
  publication-title: Am J Transplant
– volume: 22
  start-page: 1217
  year: 2004
  end-page: 1234
  article-title: The economic implications of non-adherence after renal transplantation
  publication-title: PharmacoEconomics
– volume: 39
  start-page: 582
  year: 2017
  end-page: 593
  article-title: Factors relevant to medication non-adherence in kidney transplant: a systematic review
  publication-title: Int J Clin Pharm
– volume: 12
  start-page: 35
  year: 2011
  article-title: Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review
  publication-title: BMC Nephrol
– volume: 103
  start-page: 565
  year: 2019
  end-page: 572
  article-title: Measurement characteristics of the knowledge assessment of renal transplantation
  publication-title: Transplantation
– volume: 6
  start-page: 236
  year: 2017
  article-title: Interventions to increase adherence in patients taking immunosuppressive drugs after kidney transplantation: a systematic review of controlled trials
  publication-title: et al Syst Rev
– volume: 28
  start-page: 2290
  year: 2017
  end-page: 2301
  article-title: Understanding medication nonadherence after kidney transplant
  publication-title: J Am Soc Nephrol
– volume: 28
  start-page: 3353
  year: 2017
  end-page: 3362
  article-title: Class II eplet mismatch modulates tacrolimus trough levels required to prevent donor-specific antibody development
  publication-title: J Am Soc Nephrol
– volume: 7
  start-page: 2704
  year: 2007
  end-page: 2711
  article-title: A retrospective analysis of immunosuppression compliance, dose reduction and discontinuation in kidney transplant recipients
  publication-title: Am J Transplant
– volume: 18
  start-page: 1121
  year: 2005
  end-page: 1133
  article-title: Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review
  publication-title: Transpl Int
– volume: 95
  start-page: 326
  year: 2013
  end-page: 332
  article-title: Factors predictive of medication nonadherence after renal transplantation: a French observational study
  publication-title: Transplantation
– volume: 18
  start-page: 1270
  year: 2015
  end-page: 1281
  article-title: Pharmacist intervention in improving hypertension-related knowledge, treatment medication adherence and health-related quality of life: a non-clinical randomized controlled trial
  publication-title: Health Expect
– volume: 30
  start-page: 752
  year: 2015
  end-page: 761
  article-title: Interventions to improve medication adherence in adult kidney transplant recipients: a systematic review
  publication-title: Nephrol Dial Transplant
– volume: 68
  start-page: 588
  year: 2009
  end-page: 598
  article-title: Clinical pharmacy-led disease and medicine management programme for patients with COPD
  publication-title: Br J Clin Pharmacol
– volume: 22
  start-page: 780
  year: 2009
  end-page: 797
  article-title: Interventions to improve medication-adherence after transplantation: a systematic review
  publication-title: Transpl Int
– volume: 55
  year: 2015
  article-title: Motivational interviewing for medication adherence
  publication-title: J Am Pharm Assoc
– volume: 15
  start-page: 2921
  year: 2015
  end-page: 2930
  article-title: Rates and determinants of progression to graft failure in kidney allograft recipients with donor-specific antibody: post- DSA clinical histologic progression
  publication-title: Am J Transplant
– volume: 13
  start-page: 2364
  year: 2013
  end-page: 2373
  article-title: Improving outcomes of renal transplant recipients with behavioral adherence contracts: a randomized controlled trial
  publication-title: Am J Transplant
– volume: 100
  start-page: 2479
  year: 2016
  end-page: 2485
  article-title: Within-patient variability in tacrolimus blood levels predicts kidney graft loss and donor-specific antibody development
  publication-title: Transplantation
– volume: 77
  start-page: 769
  year: 2004
  end-page: 776
  article-title: Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review
  publication-title: Transplantation
– volume: 72
  start-page: 754
  year: 2016
  end-page: 758
  article-title: Investigating the use of Barrows cards to improve self-management and reduce healthcare costs in adolescents with blood cancer: a pilot study
  publication-title: J Adv Nurs
– volume: 16
  start-page: 206
  year: 2006
  end-page: 214
  article-title: Nonadherence with immunosuppressive drugs: U.S. compared with European kidney transplant recipients
  publication-title: Prog Transplant
– volume: 6
  start-page: 236
  year: 2017
  ident: bibr11-20406223211005275
  publication-title: et al
– ident: bibr13-20406223211005275
  doi: 10.1681/ASN.2017020216
– ident: bibr14-20406223211005275
  doi: 10.1111/jan.12883
– ident: bibr22-20406223211005275
  doi: 10.1002/lt.24023
– ident: bibr20-20406223211005275
  doi: 10.1097/TP.0000000000002349
– ident: bibr12-20406223211005275
  doi: 10.1093/ndt/gfu204
– ident: bibr19-20406223211005275
  doi: 10.1681/ASN.2017030287
– ident: bibr21-20406223211005275
  doi: 10.1111/ajt.12341
– ident: bibr3-20406223211005275
  doi: 10.1111/ajt.13347
– ident: bibr18-20406223211005275
  doi: 10.1097/TP.0000000000001040
– ident: bibr2-20406223211005275
  doi: 10.1097/TP.0b013e318271d7c1
– ident: bibr7-20406223211005275
  doi: 10.1111/j.1432-2277.2009.00881.x
– ident: bibr1-20406223211005275
  doi: 10.1097/01.TP.0000110408.83054.88
– ident: bibr10-20406223211005275
  doi: 10.1111/hex.12101
– ident: bibr5-20406223211005275
  doi: 10.1111/j.1432-2277.2005.00176.x
– ident: bibr15-20406223211005275
  doi: 10.1111/j.1600-6143.2007.01966.x
– ident: bibr17-20406223211005275
  doi: 10.1111/j.1600-6143.2009.02793.x
– ident: bibr8-20406223211005275
  doi: 10.1186/1471-2369-12-35
– ident: bibr9-20406223211005275
  doi: 10.1111/j.1365-2125.2009.03493.x
– ident: bibr4-20406223211005275
  doi: 10.2165/00019053-200422180-00006
– ident: bibr6-20406223211005275
  doi: 10.1007/s11096-017-0436-4
– ident: bibr16-20406223211005275
  doi: 10.1111/j.1600-6143.2009.02798.x
– ident: bibr23-20406223211005275
  doi: 10.1177/152692480601600304
– ident: bibr24-20406223211005275
  doi: 10.1016/S1544-3191(15)30093-5
SSID ssj0000463348
Score 2.225924
Snippet Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient...
To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient knowledge...
Aims: To assess the effect of a pharmacist-led intervention, using Barrows cards method, during the first year after renal transplantation, on patient...
SourceID doaj
pubmedcentral
hal
proquest
pubmed
crossref
sage
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 20406223211005275
SubjectTerms Drug use
Health behavior
Human health and pathology
Kidney transplants
Knowledge
Life Sciences
Original Research
Patient compliance
Patient education
Pharmacists
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hCiEuiPIMLcggJCSkiMSOnZhbi6h6gIoDSL1FfkVdaZutdtP-An44M44bsloBF66OM3bGY8_nePwNwFuhJXeFcXmnii6vrAi5MZ3LEQwH5UvvvbMx2UR9dtacn-tvs1RfFBM20gOPivuAHk5Yzj1CA1UhmjC1rLUtQ-O9EcrHq3uIemabqbgGV4qumKZjTGJY4mitCn0hbXgKySmucOaIIl8_upcLiobchZq7EZOzsK_oiU4ewoMEIdnR2PV9uBP6R3Dvazokfww_j3H96hYDW3XMsKuRmxpHM18GzxazGEeGgJXFw_U4POxyCoWhV9eBWhki-fkS9c8SBevmI0pNEe4k0QYUg7rvfR4TjrPIWPsEfpx8_v7pNE_JFnKHiG7Iy9KHTpngKldrWRsrhcOtojBBu8BD41zVWW24CI1RVmvTNaEpVOGcsgipCvEU9vpVH54DU77TCC2ctLJC3-esssFIY412uFrIOoPiVvOtS0zklBBj2ZaJfHxnsDJ4P71yNdJw_K3yMQ3nVJEYtGMB2lWb7Kr9l11l8AaNYUvG6dGXlsoKwYm2rLwpMzi8tZU2zf1NiyASQRZXHGW8nh7jrKWjGNOH1TXVIWZHXPxUBs9G05qaEqKJ13YyqLeMbqsv20_6xUVkBm8QceHHZPCOzPN3l_6oqhf_Q1UHcJ9TpE_8MXUIe8P6OryEu-5mWGzWr-LE_AW3wTix
  priority: 102
  providerName: Directory of Open Access Journals
Title Benefit of a pharmacist-led intervention for medication management of renal transplant patients: a controlled before-and-after study
URI https://journals.sagepub.com/doi/full/10.1177/20406223211005275
https://www.ncbi.nlm.nih.gov/pubmed/33868624
https://www.proquest.com/docview/2569012629
https://www.proquest.com/docview/2515069636
https://hal.science/hal-03270361
https://pubmed.ncbi.nlm.nih.gov/PMC8024450
https://doaj.org/article/7433b22d08564508a7579b1e8dda36d9
Volume 12
WOSCitedRecordID wos000637593600001&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2040-6231
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000463348
  issn: 2040-6223
  databaseCode: DOA
  dateStart: 20190101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2040-6231
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000463348
  issn: 2040-6223
  databaseCode: 7X7
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Nursing & Allied Health Database
  customDbUrl:
  eissn: 2040-6231
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000463348
  issn: 2040-6223
  databaseCode: 7RV
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/nahs
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2040-6231
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000463348
  issn: 2040-6223
  databaseCode: BENPR
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2040-6231
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000463348
  issn: 2040-6223
  databaseCode: PIMPY
  dateStart: 20160101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3di9NAEB-8nogvfn9EzxJFEIRwSTbZZH2Rq9xxglfKoVKfwn7FK9Sktr37C_zDndlucy3Fe_ElkM1mk81OZn6ZmfwG4C0TeapjqaOax3WUKWYjKWsdIRi23CTGGK1csYliOCzHYzHyDreFT6tc60SnqE2ryUd-iKYZTVfKU_Fx9juiqlEUXfUlNPZgn5jKsh7sD46Ho_POy0J8WMyV0EopdY6jMfShTWJdojZqoo-gOE8p13DDODkOfzQ5F5QhuQs_d7MoN1LBnHU6uf-_83oA9zwuDY9WgvQQbtnmEdw585H3x_BngEqxnizDtg5lOFsRXqOIRFNrwslG4mSIKDh0EXu35uGvLr-GTp1busrSMapPcVFDz-u6-ICj-rR5GlFZHAYXtDGRq2IeOhrcJ_Dt5Pjrp9PIV3CINMLEZZQkxtZcWp3pQuSFVDnT-P3JpBXaprbUOquVkCmzpeRKCFmXtox5rDVXiNNi9hR6TdvY5xByUwvEKzpXeYYGVSuurMylkkKjCsqLAOL10lXa05tTlY1plXhG853VDuB9d8psxe1xU-cByUPXkWi5XUM7_1n5t7xCOMZUmhrEsTxD6CuLvBAqsaUxknEjAniD0rQ1xunRl4raYpYSF1pylQRwsJaUyiuURXUtJgG87g6jKqD4jmxse0l9iC4SNSoP4NlKNrtLMVa6f4ECKLakduteto80kwtHN14ijMPJBPCO5Pv6lv75qF7cPIGXcDelxCDnxzqA3nJ-aV_BbX21nCzmfdgrzr_Tdly4bdn373TfuUtwb_T5bPTjL3zEUFQ
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFD4aAwEv3C-BAQaBkJAiErtxYiSENmDqtK5CaEN7C76FVSptabsh3vk9_EbOcdOsVcXe9sCr4ziJc3zOZ_vzdwCeC5Vxm2gbVzKp4pYRPta6sjGCYS9d6pyzJiSbyLvd4vBQfVqDP_OzMESrnPvE4Kjd0NIa-WsMzRi6uOTq3ehHTFmjaHd1nkJjZha7_tdPnLJN3u58wP_7gvPtj_vv23GdVSC2CF2mcZo6X0ntbcvmKsu1yYTFOZHQXlnPfWFtqzJKc-ELLY1Suip8kcjEWmkQOyQC270AF9GPp0Qhyz9_adZ0SH1LhIRdnIh6EkNvvZFKGk9URkU05UoyTszGhVAYMgZggDsiPuYq2F3lbC4Qz0Is3L7-v_XiDbhWo262ORsmN2HND27B5b2aV3Abfm-hy696UzasmGajmZw3DoC47x3rLdBCGWJ8FvgIwaLZ94Y9RLeOPT1lGvTi-2iyrFatnbzBVutDAdSi8dgMmuvAxSFHOwsiv3fg4Fz64C6sD4YDfx-YdJVCNGYzk7UQLlgjjdeZNlpZdLBZHkEyN5XS1uLtlEOkX6a1XvuKdUXwqrllNFMuOavyFtlfU5FEx0PBcPytrH1YiWBTGM4donTZQmCv8yxXJvWFc1pIpyJ4hta71EZ7s1NSWSI4Kb2lJ2kEG3PLLGt3OSlPzTKCp81ldHS0e6UHfnhMdUgME-OFjODebCw0jxKiCCedIsiXRsnSuyxfGfSOgph6gSAVPyaClzSeTl_pn1314OwPeAJX2vt7nbKz0919CFc5UaDCit0GrE_Hx_4RXLIn095k_Dj4DgZfz3uY_QVh36k4
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Benefit+of+a+pharmacist-led+intervention+for+medication+management+of+renal+transplant+patients%3A+a+controlled+before-and-after+study&rft.jtitle=Therapeutic+advances+in+chronic+disease&rft.au=Chambord+Jeremy&rft.au=Couzi+Lionel&rft.au=Merville%2C+Pierre&rft.au=Moreau+Karine&rft.date=2021&rft.pub=SAGE+PUBLICATIONS%2C+INC&rft.issn=2040-6223&rft.eissn=2040-6231&rft.volume=12&rft_id=info:doi/10.1177%2F20406223211005275
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2040-6223&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2040-6223&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2040-6223&client=summon